Evidence map›Paper›PMID 33718070›Full record

ArticleTranslational andrology and urology2021

Identification of genes that correlate clear cell renal cell carcinoma and obesity and exhibit potential prognostic value.

Jiale Zhou, Zhaolin Yang, Xiaorong Wu, Jin Zhang, Wei Zhai, Yonghui Chen

Abstract read
In one paragraph

Article in Translational andrology and urology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Renal Cell Cancer and Obesity.International journal of molecular sciences · 2022
    Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jiale ZhouDepartment of Urology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
Zhaolin YangDepartment of Urology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
Xiaorong WuDepartment of Urology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
Jin ZhangDepartment of Urology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
Wei ZhaiDepartment of Urology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
Yonghui ChenDepartment of Urology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRenal cell carcinoma (RCC) is a common urologic malignancy. Although the relationship between clear cell RCC (ccRCC) and obesity has been well-established by several large-scale retrospective studies, the molecular mechanisms and genetic characteristics behind this correlation remains unclear. In the current study, several bioinformatics tools were used to identify the key genes in ccRCC related to obesity.

methodsMicroarray data comparing ccRCC with normal renal tissues in patients with and without obesity were downloaded from the GEO database for screening of differentially expressed genes (DEGs). The DEGs were verified with expression level and survival analysis using several online bioinformatics tools.

resultsIn the current study, the differential expression of five genes correlated with both ccRCC and obesity;

conclusionsIn conclusion, the five genes differentially expressed in ccRCC and obesity are related to disease progression and prognosis, and therefore could provide prognostic value for patients with ccRCC.

Indexed as

biomarkerClear cell renal cell carcinoma (ccRCC)obesityprognosis

Identifiers

PMID33718070
PMCPMC7947457

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.